Introduction
Parkinson's disease (PD) is the most common neurodegenerative movement disorder comprising of motor symptoms that include tremor, rigidity and bradykinesia (Klockgether, 2004) . The cardinal neuropathological features of PD include progressive loss of dopaminergic terminals in the striatum with subsequent death of neurons in the substantia nigra pars compacta (Hornykiewicz, 2002) , and presence of cytoplasmic, α-synuclein-positive inclusions called Lewy bodies (Forno, 1987) . The causes of degeneration, cell death and inclusion formation in sporadic PD is not clearly understood, though both genetic and environmental factors appear to play a crucial role. Experimental animal models and familial cases of PD, though few, have provided crucial insights into PD pathogenesis. Defective clearance of modified, toxic proteins via the ubiquitin proteasome system, mitochondrial dysfunction and oxidative stress appear to play a key role in cell death and protein aggregation (Abou-Sleiman et al., 2006; Dawson and Dawson, 2003) .
One of the well-examined physiological pathways leading to cell death is programmed cell death (PCD) or apoptosis and is a process intrinsic to a cell that when activated causes its destruction (Vila and Przedborski, 2003) . The key mediators of PCD are the proteolytic enzymes called 'caspases ' (Vila and Przedborski, 2003) . Caspase activation can be triggered by activation of death receptors such as Fas located on the cell surface of target cells (Nagata, 1997). FAF1 or Fas-associated factor 1 is a Fas-binding protein (Ryu and Kim, 2001) , whose the role in apoptotic cell death is not well understood. Interestingly however, the human FAF1 gene has been localized to chromosome 1p32 (Kikyo et al., 1997) at the PARK 10 locus, a locus that has been recently associated with late-onset Parkinson's disease (Hicks et al., 2002) . Furthermore, in vitro evidence suggests that FAF1 can initiate or enhance Fas-mediated apoptotic cell death (Chu et al., 1995) . Therefore, in this study we have examined the role of this novel protein, FAF1, in PD pathogenesis. We demonstrate here that FAF1 expression level is specifically upregulated in PD and in Alzheimer's disease (AD) cases with extensive PD pathology (AD/PD), and increased FAF1 expression in a cell model, with or without PD-related stressors, is associated with cell death.
Materials and methods
Collection and preparation of human case material Human brain tissues were obtained from the brain bank incorporated into our Neurodegenerative Disease Center. The brain bank consists of an extensive postmortem brain collection from patients with AD, PD, and related neurodegenerative diseases. When a brain is Neurobiology of Disease 31 (2008) 309-315 
